Follow-up in Gynecological Cancer Survivors

Inclusion Criteria: * Histological proven gynecological cancer (cervical, endometrial, ovarian (including fallopian tube and peritoneal primary), vulva). * FIGO stage I-IV before completion of primary therapy. * Disease-free without any evidence of relapse: no symptoms or signs potentially indicating recurrent disease (assessed according to standard clinical parameters using physical and gynecological examination, blood tests, CA 125 (ovarian cancer), or radiological imaging techniques). * At least 6 months but no more than 5 years since completion of primary treatment. * Performance status 0, 1 or 2 (WHO scale). * Age ≥ 18 years. * Ability to understand and fill out questionnaires. * Written informed consent according to ICH/GCP, and national/local regulations. Exclusion Criteria: * Other cancer diagnosis in the past 5 years. * Patients participating in interventional clinical studies with Quality of Life as primary endpoint. * Any psychological (including pre-existing psychiatric disorders), familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.